Mexico - Delayed Quote MXN

ICLR.MX,0P0001N5FJ,0 (ICLR.MX)

5,293.37

0.00

(0.00%)

At close: July 19 at 2:00:00 PM CST

Are ICON Public Limited Company's (NASDAQ:ICLR) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

ICON (NASDAQ:ICLR) has had a rough three months with its share price down 29%. However, the company's fundamentals look...

Simply Wall St. 13 hours ago

ICLR
ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption

DUBLIN, December 05, 2024--ICON announces results from a global survey of biopharma professionals on AI and digital innovation adoption within clinical research.

Business Wire 7 days ago

ICLR
Baird cuts Icon target, names ‘Bullish Fresh Pick’

Baird analyst Eric Coldwell lowered the firm’s price target on Icon (ICLR) to $225 from $249 and keeps a Neutral rating on the shares. The firm is concerned about sector fundamental performance through the first half of 2025, at minimum, but says Icon’s current valuation “feels so oversold we are willing to make a near-term positive trading call.” Near-term volatility is expected for contract research organizations, while long-term secular drivers remain in place, the analyst tells investors in

TipRanks 21 days ago

ICLR
Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?

ICON Public Limited Company ( NASDAQ:ICLR ) saw significant share price movement during recent months on the NASDAQGS...

Simply Wall St. 28 days ago

ICLR
ICON plc to Present at the Jefferies London Healthcare Conference

DUBLIN, November 13, 2024--ICON plc to Present at the Jefferies London Healthcare Conference

Business Wire 29 days ago

ICLR
ICON Third Quarter 2024 Earnings: Misses Expectations

ICON ( NASDAQ:ICLR ) Third Quarter 2024 Results Key Financial Results Revenue: US$2.03b (down 1.2% from 3Q 2023). Net...

Simply Wall St. last month

ICLR
ICON Reports Third Quarter 2024 Results

DUBLIN, October 23, 2024--ICON Reports Third Quarter 2024 Results

Business Wire last month

ICLR
ICON plc Schedules Third Quarter 2024 Earnings Conference Call

DUBLIN, September 27, 2024--ICON plc Schedules Third Quarter 2024 Earnings Conference Call

Business Wire 2 months ago

ICLR
ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape

DUBLIN, September 12, 2024--ICON shares results of a survey of over 100 oncology drug development professionals on the current state of emerging oncology treatment development.

Business Wire 2 months ago

ICLR
Is There An Opportunity With ICON Public Limited Company's (NASDAQ:ICLR) 32% Undervaluation?

Key Insights Using the 2 Stage Free Cash Flow to Equity, ICON fair value estimate is US$446 Current share price of...

Simply Wall St. 3 months ago

ICLR
ICON plc to Present at the Baird 2024 Global Healthcare Conference

DUBLIN, September 03, 2024--ICON plc to Present at the Baird 2024 Global Healthcare Conference

Business Wire 3 months ago

ICLR
Those who invested in ICON (NASDAQ:ICLR) five years ago are up 110%

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on a lighter note, a...

Simply Wall St. 3 months ago

ICLR
ICON Announces Appointment of New Chief Financial Officer

DUBLIN, August 14, 2024--ICON Announces appointment of new Chief Financial Officer

Business Wire 3 months ago

ICLR
ICON Second Quarter 2024 Earnings: Misses Expectations

ICON ( NASDAQ:ICLR ) Second Quarter 2024 Results Key Financial Results Revenue: US$2.12b (up 4.9% from 2Q 2023). Net...

Simply Wall St. 4 months ago

ICLR
ICON Reports Second Quarter 2024 Results

DUBLIN, July 24, 2024--ICON Reports Second Quarter 2024 Results

Business Wire 4 months ago

ICLR
ICON announces results of Annual General Meeting and changes to the Board of Directors

DUBLIN, July 24, 2024--ICON announces results of Annual General Meeting and changes to the Board of Directors

Business Wire 4 months ago

ICLR
ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer

DUBLIN, July 10, 2024--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading business and industry awards recognising the company’s leadership position in the clinical research industry, in addition to its efforts in inclusion, sustainability and as an employer of choice.

Business Wire 5 months ago

ICLR
Is ICON Public Limited Company's (NASDAQ:ICLR) Recent Stock Performance Influenced By Its Financials In Any Way?

ICON's (NASDAQ:ICLR) stock up by 1.5% over the past week. As most would know, long-term fundamentals have a strong...

Simply Wall St. 5 months ago

ICLR
ICON plc Schedules Second Quarter 2024 Earnings Conference Call

DUBLIN, July 01, 2024--ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second quarter 2024 after the market closes on Wednesday, July 24, 2024. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, July 25, 2024 at 8:00am ET.

Business Wire 5 months ago

ICLR
Is Now The Time To Put ICON (NASDAQ:ICLR) On Your Watchlist?

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Simply Wall St. 5 months ago

ICLR

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

ICLR.MX,0P0001N5FJ,0 (ICLR.MX)

Are ICON Public Limited Company's (NASDAQ:ICLR) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption

Baird cuts Icon target, names ‘Bullish Fresh Pick’

Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?

ICON plc to Present at the Jefferies London Healthcare Conference

ICON Third Quarter 2024 Earnings: Misses Expectations

ICON Reports Third Quarter 2024 Results

ICON plc Schedules Third Quarter 2024 Earnings Conference Call

ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape

Is There An Opportunity With ICON Public Limited Company's (NASDAQ:ICLR) 32% Undervaluation?

ICON plc to Present at the Baird 2024 Global Healthcare Conference

Those who invested in ICON (NASDAQ:ICLR) five years ago are up 110%

ICON Announces Appointment of New Chief Financial Officer

ICON Second Quarter 2024 Earnings: Misses Expectations

ICON Reports Second Quarter 2024 Results

ICON announces results of Annual General Meeting and changes to the Board of Directors

ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer

Is ICON Public Limited Company's (NASDAQ:ICLR) Recent Stock Performance Influenced By Its Financials In Any Way?

ICON plc Schedules Second Quarter 2024 Earnings Conference Call

Is Now The Time To Put ICON (NASDAQ:ICLR) On Your Watchlist?